Ubiquitin-proteasome Pathway-linked Gene Signatures as Prognostic Indicators in Prostate Cancer
Anticancer Research · 2025
DOI: 10.21873/anticanres.17562 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, 2025. Verfasst von Yasuo Takashima und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genomic Medical Sciences, Kyoto Prefectural University of Medicine, Kyoto, Japan. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Biomarkers, Tumor, Proteasome Endopeptidase Complex, Ubiquitin. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Genomic Medical Sciences, Kyoto Prefectural University of Medicine, Kyoto, Japan.
- Department of Mathematics and Statistics in Medical Sciences, Kyoto Prefectural University of Medicine, Kyoto, Japan.
- Department of Genomic Medical Sciences, Kyoto Prefectural University of Medicine, Kyoto, Japan; tashiro@koto.kpu-m.ac.jp.
Zitieren
APA
Takashima, Y., Yoshii, K., Tanaka, M., & Tashiro, K. (2025). Ubiquitin-proteasome Pathway-linked Gene Signatures as Prognostic Indicators in Prostate Cancer. Anticancer Research. https://doi.org/10.21873/anticanres.17562
Vancouver
Takashima Y, Yoshii K, Tanaka M, Tashiro K. Ubiquitin-proteasome Pathway-linked Gene Signatures as Prognostic Indicators in Prostate Cancer. Anticancer Research. 2025. doi:10.21873/anticanres.17562
BibTeX
@article{Takashima2025,
author = {Takashima, Yasuo and Yoshii, Kengo and Tanaka, Masami and Tashiro, Kei},
title = {Ubiquitin-proteasome Pathway-linked Gene Signatures as Prognostic Indicators in Prostate Cancer},
journal = {Anticancer Research},
year = {2025},
doi = {10.21873/anticanres.17562}
}
EUVIMED